AlcheMeat—how the future of animal production rests with biochemistry
Author(s) -
Marie Gibbons
Publication year - 2018
Publication title -
the biochemist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 7
eISSN - 1740-1194
pISSN - 0954-982X
DOI - 10.1042/bio04004013
Subject(s) - regenerative medicine , biopharmaceutical , production (economics) , crispr , microbiology and biotechnology , biology , business , stem cell , genetics , gene , economics , macroeconomics
Innovations in regenerative medicine, stem cell biology, tissue engineering, and biopharmaceutical production are responsible for saving countless lives and completely transforming healthcare. But what if this research could be applied to more than individual medical treatments? New applications within these fields could further address public safety concerns, global malnourishment, environmental issues, and animal abuse. In fact, these types of studies could lead to prevention of many of the diseases they initially set out to treat! Foci within these areas, such as telomerase expression, cell differentiation, induced pluripotency, three-dimensional tissue formation, recombinant protein production and CRISPR, are now being used for something entirely different — making meat.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom